Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.

Biotechnology

Tessera Therapeutics

Michael Severino

David Tefft

Joel Nichols

Cecilia Cotta-Ramusino

Yohann Potier

Jody Massey

Cynthia Patton

Anne-Virginie Eggimann

Hari Pujar

Howard Liang

David Davidson

Becky Lillie

Michael Holmes

Vikram Ranade

Jacob Rubens

The Engineering and Data Science team at Tessera Therapeutics leverages advanced machine learning, data analytics, and software engineering to support the company's pioneering work in Gene Writing. This multidisciplinary team collaborates to develop computational tools, automation systems, and data platforms for designing, testing, and optimizing genetic therapies. Their work is crucial for transforming genomic data into actionable insights that drive therapeutic innovation.

Engineering and Data Science

Scientific Research Team

Directors & Managers

Engineering and Data Science

About

Team members

Other teams at Tessera Therapeutics

Scientific Research Team

Directors & Managers